MorphoSys appoints new head of research antibody business
This article was originally published in Scrip
Executive Summary
MorphoSys (Germany) has appointed Dieter Feger head of its AbD Serotec business for research and diagnostic antibodies. He joins from Abbott Diagnostics, where, for the last four years, he served as marketing director – global marketing, most recently with responsibility for infectious diseases. Mr Feger succeeds Dieter Lingelbach, who has left MorphoSys.